2017
DOI: 10.1042/bsr20160608
|View full text |Cite
|
Sign up to set email alerts
|

Mega primer-mediated molecular cloning strategy for chimaeragenesis and long DNA fragment insertion

Abstract: Molecular cloning methods based on primer and overlap-extension PCR are widely used due to their simplicity, reliability, low cost and high efficiency. In this article, an efficient mega primer-mediated (MP) cloning strategy for chimaeragenesis and long DNA fragment insertion is presented. MP cloning is a seamless, restriction/ligation-independent method that requires only three steps: (i) the first PCR for mega primer generation; (ii) the second PCR for exponential amplification mediated by the mega primers a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 17 publications
0
5
0
Order By: Relevance
“…The construct h1prom0-pGL3 contained the whole 600 bp genomic sequence (Chr5:133340586-133341185); h1prom1-pGL3 contained a 200 bp genomic sequence (chr5:133340586-133340786) and, similarly, h1prom2-pGL3 (chr5:133340786-133340986), and h1prom3-pGL3 (chr5:133340986-133341185). pcDNA3.0-NRF-1 and pcDNA3.0-HIF-1 constructs were obtained by PCR cloning strategy (22)(23)(24). In brief, coding sequences of TFs amplified from HeLa cDNA were modified at terminal ends by adding sequences complementary to pcDNA 3.0 vector and recombinants generated by PCR.…”
Section: Plasmid Constructs and Mutagenesismentioning
confidence: 99%
“…The construct h1prom0-pGL3 contained the whole 600 bp genomic sequence (Chr5:133340586-133341185); h1prom1-pGL3 contained a 200 bp genomic sequence (chr5:133340586-133340786) and, similarly, h1prom2-pGL3 (chr5:133340786-133340986), and h1prom3-pGL3 (chr5:133340986-133341185). pcDNA3.0-NRF-1 and pcDNA3.0-HIF-1 constructs were obtained by PCR cloning strategy (22)(23)(24). In brief, coding sequences of TFs amplified from HeLa cDNA were modified at terminal ends by adding sequences complementary to pcDNA 3.0 vector and recombinants generated by PCR.…”
Section: Plasmid Constructs and Mutagenesismentioning
confidence: 99%
“…Based on our electrophysiology analysis of the wild-type GluK1-1a/GluK1-2a receptors, structural analysis of GluK1-1a EM , and recent reports that suggest that the presence of the positive patches in GluK2 ATD affects the interaction with Neto proteins (He et al, 2021b; Li et al, 2019; Vinnakota et al, 2021), we performed SDM to understand the role of splice residues in the receptor kinetics. All splice mutations were introduced in the wild-type (species) GRIK1-1a pRK7 construct for electrophysiology, as well as the GRIK1-1a EM -EGFP-His 8 -pEGBacMam construct for surface expression and pull-downs using the (overlap PCR) ligation-free cloning approach (Zhang et al, 2017). In brief, we performed the 2 sets of PCR using standard cloning primers (∼300 bp upstream and downstream of the mutation) and the mutant primers as listed in Supplemental Table 1 to obtain the fragment containing our mutation of interest and flanking regions corresponding to the wild-type GluK1-1a.…”
Section: Methodsmentioning
confidence: 99%
“…Based on our electrophysiology analysis of the wild-type GluK1-1a/GluK1-2a receptors, structural analysis of GluK1-1a EM , and recent reports that suggest that the presence of the positive patches in GluK2 ATD affects the interaction with Neto proteins (He et al, 2021b ;Li et al, 2019 ;Vinnakota et al, 2021 ), we performed SDM to understand the role of splice residues in the receptor kinetics. All splice mutations were introduced in the wild-type GRIK1-1a pRK7 construct for electrophysiology, as well as the GRIK1-1a EM -EGFP-His 8 -pEGBacMam construct for surface expression and pull-downs using the ligation-free cloning approach (Zhang et al, 2017 ). Clones were confirmed by sequencing.…”
Section: Site-directed Mutagenesis (Sdm)mentioning
confidence: 99%